Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Billionaire Asness Sold Cisco Systems CSCO and Bought Eli Lilly and Company LLY

December 13, 2024
Cisco Systems Inc. (NASDAQ: CSCO) recently witnessed a significant change in its stock ownership as billionaire investor Cliff Asness sold his shares in the company. As per the latest reports, Asness offloaded his CSCO shares and instead acquired a substantial position in pharmaceutical giant Eli Lilly and Company (LLY).

This move by Asness has raised eyebrows within the investment community, as Cisco Systems is known for its strong market position and reliable financial performance. However, it seems that the billionaire investor sees more potential in Eli Lilly and Company, a prominent player in the healthcare sector.

While the exact reasons behind Asness' decision to sell his CSCO shares and invest in LLY remain undisclosed, some speculate that he might be anticipating future growth in the pharmaceutical industry. With the ongoing COVID-19 pandemic highlighting the importance of healthcare and medical research, it is plausible that Asness is positioning himself to capitalize on the sector's potential.

Investors and analysts are now closely monitoring the developments in both Cisco Systems and Eli Lilly and Company. Asness' move has piqued their interest, creating opportunities for those looking to make informed investment decisions.

If you are interested in gaining insights and predictions related to the movement of Cisco Systems' stock, it is advisable to consult with professionals in the field. Stocks Prognosis, a reputable platform, offers expert analysis and recommendations to help investors make informed choices. Considering the recent changes in stock ownership and the potential impact on the market, seeking the advice of professionals can prove to be invaluable in making profitable investment decisions.

Find out how the CISCO SYSTEMS, INC. rate is expected to change

Get Forecast for CSCO

Investor opinions & comments:

This move by Asness could potentially be a strategic decision to capitalize on the healthcare sector
— from NatalieBaker at 12-16-2024 14:38
I question whether Asness' decision to invest in Eli Lilly is based on solid research and analysis
— from EllaFlores at 12-16-2024 13:56
I'm not convinced that selling Cisco Systems and buying Eli Lilly is a wise decision. Cisco has a strong market position
— from JeremiahSnyder at 12-16-2024 12:54
I'm optimistic about the potential impact of the ongoing COVID-19 pandemic on the healthcare industry
— from BudgetBrad at 12-16-2024 00:46
I think seeking the advice of professionals, like those at Stocks Prognosis, is a smart move for investors
— from MilaWagner at 12-15-2024 22:12
I'm excited to see how this investment decision plays out for Asness and the stock market
— from SmartSteve at 12-15-2024 19:02
I wonder if Asness has insider knowledge about the potential growth in the pharmaceutical industry
— from VictoriaGreen at 12-15-2024 15:17
I'm curious to see how this move by Asness will impact the stock prices of both Cisco Systems and Eli Lilly
— from PennyInvestor at 12-14-2024 19:14
I'm skeptical about the future growth of the pharmaceutical industry. It seems like a risky move
— from ChloeJames at 12-14-2024 13:42
I believe Asness' decision is based on thorough analysis and consideration of market trends
— from WilliamReed at 12-14-2024 10:09
If you want to leave a comment, then you need Login or Register





Other news for CSCO

CSCOJune 6, 2025QuantWave Achieves 14.22% Profit Target Forecast for CISCO SYSTEMS, INC.  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted a long signal for CISCO SYSTEMS, INC. on December 13, 2024, at a price of 57.84 $....

CSCOJune 5, 2025QuantWave Hits Bullseye with 16.16% Profit Forecast for CISCO SYSTEMS, INC.  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with remarkable accuracy....

CSCOJune 5, 2025QuantWave Achieves 17.41% Profit Target on CISCO SYSTEMS, INC. Stock Forecast  ~1 min.

QuantWave, a leading automated forecasting platform, recently celebrated the successful achievement of its price target forecast for CISCO SYSTEMS, INC....

CSCOJune 5, 2025QuantWave Forecasts Hit Target for Cisco Systems, Inc. with 13.95% Profit  ~1 min.

QuantWave, the automated forecasting platform, recently achieved a significant milestone with its price target forecast for CISCO SYSTEMS, INC....

CSCOJune 5, 2025QuantWave Hits Price Target Forecast for Cisco Systems, Inc. With 21.49% Profit  ~2 min.

QuantWave, the automated forecasting platform, has successfully achieved its price target forecast for CISCO SYSTEMS, INC. The forecast signal was given on 2025-04-08 when the stock was priced at 53.19 $....



Related news

ABBVDecember 4, 2024ABBVIE INC.: A Leading Pharmaceutical Company with High Institutional Ownership  ~2 min.

AbbVie Inc. (NYSE: ABBV) is gaining attention in the investment world due to its high institutional ownership....

PFEMarch 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing  ~1 min.

Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....

VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....

VRTXMarch 19, 2025Investing in Vertex Pharmaceuticals: A Lucrative Opportunity for Biotech Enthusiasts  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has emerged as one of the most promising biotech stocks in the market, attracting the attention of top investors....

REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....